from Yahoo Finance https://ift.tt/2YXxVPV
-
LabCorp expands availability of at-home sample collection kit for COVID-19 testing
from Yahoo Finance https://ift.tt/2T1fHcN
-
U.S. FDA declines to review Bristol Myers, bluebird therapy for multiple myeloma
from Yahoo Finance https://ift.tt/2WUgWeC
The Latest
-
Cyclopharm share price rockets 22% higher on FDA application approval
-
Why Afterpay, CSL, Fortescue, & Newcrest shares are dropping lower
-
Why ALS, Metcash, NAB, & Pointsbet shares are racing higher
-
Hedge Funds Have Never Been This Bullish On DexCom, Inc. (DXCM)